ABSTRACT
INTRODUCTION
The so-called "asymptomatic meningiomas"(AMs) are those found incidentally by autopsy or computerized tomography (CT) / magnetic resonance imaging (MRI) scannings for health examinations, or cerebral injury, cerebrovascular diseases and some symptoms not caused by meningiomas. The detection rate of AMs is increasing with the development of diagnostic imaging modalities, especially the widespread use of CT and MRI equipment and the prevalence of health examination. However, there are still controversies about management strategy for AMs because some may remain silent until the patient's death. From February 2003 to May 2013, 122 cases of AMs were treated surgically in Qilu Hospital of Shandong University, representing 12.8% of all intracranial meningiomas during the same period.
MATERIAL and METHODS

Patient Populations
There were 39 males and 83 females in this group. Their ages ranged from 38 to 72 years with a mean of 58.6 years. All cases were found incidentally by CT or MRI scannings. The reasons for CT or MRI scannings include health examinations in 14 cases, craniocerebral trauma in 52, cerebrovascular diseases in 11, and some symptoms not caused by intracranial meningiomas in 45.
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Radiological Images
All cases were given CT or/and MRI scannings in this series. Enhanced CT or MRI revealed moderate to marked enhancement of tumors. The findings of the last CT or/and MRI examinations before surgery were shown in Table I .
Management Strategy
Of the 122 cases of AMs, 18 cases younger than 50 years old were treated surgically without dynamic observation after meningiomas were found, and 22 were resected after a less than three-month follow-up because patients asked for operations. Of the other 82 cases followed up by enhanced CT or MRI every 3-12 months, 44 had no obvious growth during a period from the initial detection by CT or MRI to the last preoperative examination of CT or MRI, ranging from three to nineteen months (mean 12.5 months), but 14 became symptomatic due to the aggravation of peritumoral edema. Tumor growth was observed in the other 38 cases on the last images of CT or MRI, in contrast with the initials during a period from the initial detection by CT or MRI to the last preoperative examination of CT or MRI, varying between six and thirty-six months (mean 24 months), and the annual increase varied from 0.2 to 1.8 cm (mean 0.4 cm) in maximum diameter. However, the meningioma-related symptoms appeared only in 20 cases.
RESULTS
Surgical Results
Simpson I or II resection (18) was achieved in all cases. Postoperatively, the sporadic hemorrhage in the surgical field occurred in one case at the age of 72 years old. No death and severe complications or permanent neurological sequelae were observed in this series.
Pathological Results
Pathology revealed that benign meningiomas were confirmed in 121 cases and malignant in 1. In the subtypes, 52 cases were psammomatous, 38 fibroblastic, 28 meningothelial, 3 mixed and 1 malignant.
Follow-up Results
There was no recurrence after a follow-up of 12-72 months (mean 33 months). The patient with malignant meningioma was given radiotherapy after surgery and had not reccurence of tumor at 15 months after operation.
DISCUSSION
Incidence Rate
It is difficult to estimate accurately the incidence rate of AMs because they are found incidentally. The incidence rate of AMs detected at autopsy was 1%-2.3%, and more than 3% of those over 60 years old (3, 11) . An estimated 0.5%-3% of the population has an incidental AM (17, 20) . With the wide use of neuroimaging examinations and the decrease of autopsy, the rate of AMs detected incidentally by neuroimaging has increased year by year from 0.16:100,000 per year to 2.28:100,000 per year, whereas the rate of meningiomas found incidentally at autopsy has decreased from 5.25:100,000 per year to 3.92:100,000 per year (5) . The proportions of AMs to all meningiomas reported in literature varied widely between 20.7% and 75% (3, 5, 14, 16, 21) . The main causes of this wide gap include the different constitution of patients' age, the prevalence of CT and/or MRI, the different research subjects and diverse research methods (3). Nishizaki et al reported 108 cases of AMs treated surgically represented 20.7% of all meningiomas during the same period (14) . Go et al reported 35 patients with AMs followed-up dynamically accounted for 28.9% of all meningiomas (5). It's reported that 38.9% of all 1536 meningiomas had no symptoms by Kuratsu et al (6) . Radhakrishnan found 75% of 136 meningiomas were asymptomatic during population statistics (16) . Generally thinking, the incidence rate of AMs increases continuously with age (5, 13, 15, 17) . According to the statistical data of autopsy by Nakasu and his colleagues, the age incidences of AMs were 0.5% younger than 40 years, 1.2%% 40-60, 2.4% 60-69, 3.6% 70-79 and 4.6% over 80, respectively (11) . And 21% of 75 meningioma patients over 60 years old, treated surgically by Award et al, were asymptomatic (1). Niiro et al observed 92 cases of meningioma at the age of over 70 years old, and 69 cases (75%) had no symptoms (13). Of the 1536 meningiomas reported by Kuratsu et al, the proportion of patients with AMs 
Clinical Characteristics
Compared with symptomatic meningiomas, AMs exhibit some clinical characteristics as follows (2-7, 10,11,13-15,22):
1. The tumors occur frequently in the aged. The brain atrophy of the elderly is the likely one of factors making meningiomas asymptomatic during a certain period. However, the mean age of our series is lower than that reported in the literature, which may be relate to the selection of cases because the surgical treatment is usually given the patients with AMs at the relative young age.
2. The proportion of tumors in females is much higher, ranging from 68% to 91%.
3. The tumors are usually small, with a mean 2.8 cm diameter, infrequently accompanied by peritumoral edema. The sizes of tumors are often less than 1 cm in diameter when patients' ages are under 30 years and the proportion of tumors greater than 3 cm in diameter increases when over 50 years.
4. The cerebral convexity is the most common site of AMs, accounting for 41.7% to 65.7%.
5. Calcification rates of tumors increase (18%-68.6%), but cystic or necrotic generation, intratumoral hemorrhage happen rarely.
6. The rate of complete resection is higher.
7. Psammomatous, fibroblastic and meningothelial meningiomas constitute the majority of subtypes, while malignant meningiomas are rare (about 1%).
Investigation of Neuroimaging
Surgical management must be based on the natural history of AMs. However, it was difficult to investigate the history of AMs before the era of CT. Now follow-up of CT or MR imaging associated with clinical symptomatology make it possible to study the natural history for a certain period. /yr) and the relative growth rates ranged from 0.48% to 2.8% (mean 14.6%). The tumor doubling time ranged from 1.27 to 143.5 years (mean 21.6 years). Though the different methods were used to calculate the growth rate of tumor in the literature, the conclusions were consistent. That is to say, most AMs do not grow or only grow slowly within a certain period. In conclusion, the surgical treatment of AMs was selectively performed under the guidance of continuous neuroimaging observations.
Management and Prognosis
No Class I or Class II evidence is available to support the treatment strategy and all recommendations are based on Class III evidence related to expert opinions and retrospective case series (17) . It is still controversial whether AMs need to be treated surgically or not, especially in the case of the senile with small and calcified tumor. A wait-and-see strategy is often beneficial for asymptomatic elderly patients. It's suggested that patients with AMs should be firstly followed up for 3-12 months and then the next action is decided (2-7,9-17, [19] [20] [21] [22] . It is necessary to monitor the patients with AMs with serial neuroimaging, usually starting with a follow-up in every 3-6 months and then 6-9 months, and thereafter 1 year because the growth rate is unpredictable in each individual case (3, 7, 11) . In our opinion, surgery should be recommended immediately if the tumor is large with obvious mass effect or suspected of malignancy. It is hoped that AMs are removed surgically before the appearance of symptoms in respect that the radical resection is usually easier to be achieved by this time (7) . The follow-up should be stopped and surgery or γ-knife should be considered once the changes as follows are observed during the neuroimaging and clinical monitoring (7, 8, 9, 11, 13 ):
1. The tumor grows rapidly, with the relative growth rate of more than 25% in an half year.
2. The tumor shows high signal on MR T 2 weighted images and has heterogeneous enhancement, revealing the necrosis and high proliferating potential of tumor.
3. Not only severe edema surrounding the tumor but also the absence of tumoral calcifications are detected.
removal should be advised to repeat CT or MRI scannings at regular intervals or to take other treatments.
Theoretically, the prognosis of AMs is good after surgery. However, the surgical results of AMs are not much better than that of symptomatic meningiomas due to their older ages. Nishizaki et al reported that the mortality and disability rates of 75 AMs and 356 symptomatic meningiomas were 5.3% and 6.1%, respectively, and no obvious difference was found (14) . Though no death occurred in 87 AMs treated surgically by Kuratsu et al (6) , the postoperative disability rate was as high as 11.4%. The surgical result is related to patient's age to a great degree. The postoperative disability rate was 9.4%-23.3% in the cases over 70 years and 3.5%-12% under 70 years (6, 9, 21) . Awad et al. also reported that the postoperative mortality rate and perioperative disability rate were 6.6% and 30% respectively in the cases older than 60 years (1) . In a word, the senility is the main factor influencing the surgical effect. In our series, no death or disability appeared, which was related to the appropriately selective cases, right operative opportunity as well as surgical skills.
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4. The tumor-related symptoms appear though the tumor has no obvious growth.
5. The tumor grows invasively into the close-by dura mater, venous sinus, brain, skull and others.
We also advise the patients with AMs to adopt surgical removal if they are medically fit for surgery as well as most likely to have complete removal of tumor. The reasons for this proposal include: 1) modern microneurosurgical techniques decrease greatly the surgical mortality and disability of patients with meningioma, and the meningioma is one of tumors with the best surgical effect; 2) so far, no data of lifetime follow-up from a large sample of patients with AMs has been available, and it is impossible to compare the lifetime follow-up results with the surgical effects. In addition, it does not mean the tumors will stop growing even if they grow insignificantly or slowly in a certain time. In fact, the absolutely static meningiomas are rare; 3) the young patients with AMs should be given actively surgical resection because their remaining years are longer and the surgical risk-effect ratio will increase when the tumors grow with age in the future. However, whether older patients need to be treated surgically or not should be considered carefully.
Decisions about therapy need to weigh the natural history of AMs, the risks of intervention, and patient preferences.
The following risk factors should be considered when the operative opportunity is determined.
1. Age: Age is a crucial element in deciding whether to treat surgically AMs. Prophylactic resection is suggested in the younger cases with AMs because of a higher growth rate and shorter doubling time of tumors (17) . Instead, caution is advised if the operation is given to the patients older than 70 years because the morbidity and mortality of open surgery are increased in those senile patients.
2. Location: Tumor location was not found to be a significant predictive factor (17) . But, if the patients are young, it's a reasonable recommendation to remove surgically the tumors located in these regions as early as possible, such as convexity, parasagittal, falx, sphenoidal ridge, saddle area, olfactory groove, and cerebellopontine angle, considering the excellent surgical effects.
3. Mass effect: It is proposed that AMs with mass effect due to their larger volume or peritumoral edema should be removed surgically because an overwhelming majority of AMs larger than 4 cm in diameter will become symptomatic in a short time (7).
4. Surgical risk-effect ratio: For the cases with high surgical risk-effect ratio, such as AM in pineal region or in advanced age, non-surgical therapy (e.g. γ-knife) instead of immediate surgical therapy may be recommended. 
